Ankylosing spondylitis is a chronic inflammatory disease of the attachment points between tendons, ligaments, or capsule and bone. It causes arthritis of the joints, mainly the spine and pelvis (sacroiliac joints). Ankylosing spondylitis can also cause inflammation of the eyes, lungs, or heart valves.
In severe cases, new bone may develop between the spinal bones. This can cause some areas of the spine to fuse. This fusion will decrease the flexibility and movement of the spine.
There is no cure for ankylosing spondylitis. Treatment is aimed at providing education and relieving the symptoms.
Treatments may include:
Medication may help to control pain and inflammation. They may include:
Over-the-counter medication such as nonsteroidal anti-inflammatory drugs (NSAIDs)
Prescription medication that suppresses the inflammation such as:
Disease-modifying antirheumatic drugs (DMARDs)
Tumor necrosis factor (TNF)-inhibitors
Physical therapy may help prevent progression and worsening of symptoms. Treatment may include:
Learning proper posture and the best positions for sleeping
Exercise program that includes:
Abdominal and back exercises (to decrease back stiffness and maintain good posture)
Breathing exercises (in cases where the rib cage is affected)
In severe cases,
hip or joint replacement
surgery may be needed. It will be done to relieve pain and help you move around easier. In some instances, spinal surgery is needed to allow an upright posture.
There are no guidelines for preventing ankylosing spondylitis because the cause is unknown.
Ankylosing spondylitis. Spondylitis Association of America website. Available at: http://www.spondylitis.org/About-Spondylitis/Ankylosing-Spondylitis. Accessed November 10, 2017.
Ankylosing spondylitis. University of Washington Orthopedics and Sports Medicine Department website. Available at: http://www.orthop.washington.edu/?q=patient-care/articles/arthritis/ankylosing-spondylitis.html. Accessed November 10, 2017.
10/2/2009 DynaMed Plus Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T143424/Ankylosing-spondylitis: FDA approves new drug to treat psoriasis. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm183851.htm. Updated April 17, 2013. Accessed December 17, 2014.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.